Benign Recurrent Intrahepatic Cholestasis (BRIC): An African Case Report

Table 2

Laboratory results.

Investigation	Reference range	26/06/16 attack 2		09/07/16 attack 2	13/07/16 attack 2			07/01/18, 20/01/18 attack 4	04/12/18 attack 5
White cell count (×109/L)	4–10	7.04
Neutrophils (%)	45–75	65
Lymphocytes (%)	25–40	26
Monocytes (%)	2–10	7
Eosinophils (%)	1–6	2
Basophils (%)	0–2	0
Red cell count (×1012/L)	4.5–6.5	5.46
Haematocrit (%)	40–54	50.6
Haemoglobin (g/dL)	13–18	16.4
Platelets (×109/L)	150–400	369
International normalised ratio (INR)									1.98
Total bilirubin (umol/L)	0–21	134.7		229.1	293.7				393
Direct bilirubin (umol/L)	0–3.4	108.4		204.9	249.3				337
Alkaline phosphatase (U/L)	52–171	288.5		313.0	370.0				692
Gamma glutamyl transferase (U/L)	2–42	18.1		8.0	9.0				12
Aspartate aminotransferase (U/L)	0–50	186.5		60.7	46.1				48
Alanine aminotransferase (U/L)	0–50	400.4		62.4	43.7				32
Total protein (g/L)	60–85								91
Albumin (g/L)	35–55								46
Hepatitis B surface antigen	Negative	Negative							Negative
Hepatitis A IgM antibody	Negative	Negative			Negative				Negative
Hepatitis A total antibody	Negative				Positive
Hepatitis C antibody	Negative			Negative					Negative
Antinuclear antibody								Negative
Antimitochondrial antibody								Negative
Anti-LKM A^±								Negative
Liver antibodies								Negative

^±Antiliver kidney microsome type 1 antibody. ASMA, AMA-M2, M2-3E, SP-100, PML, gp210, LKM-1, LC-1, SLA/LP, and Ro-52.